<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="viruses-12-01058-t002" orientation="portrait" position="float">
 <object-id pub-id-type="pii">viruses-12-01058-t002_Table 2</object-id>
 <label>Table 2</label>
 <caption>
  <p>Summary of popular drugs under consideration for repositioning for COVID-19.</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Drug</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Initial Purpose</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Side-Effects in COVID-19 Patients</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Potential Therapeutic Mode of Action for SARS-CoV-2</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Clinical Trials for COVID-19</th>
    <th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Chloroquine/Hydroxychloroquine</bold>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antimalarial medication</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Side-effects may arise with toxic dosage for patients with cardiovascular disorders</p>
      </list-item>
      <list-item>
       <p>Excessive prolong in QTc intervals which leads to ventricular arrhythmias</p>
      </list-item>
      <list-item>
       <p>Gastrointestinal upset</p>
      </list-item>
      <list-item>
       <p>Retinal toxicity and myopathy</p>
      </list-item>
     </list>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Impairs replication of virus by interfering with endosome-mediated viral entry or other pH-dependent viral replication steps</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Currently ongoing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B101-viruses-12-01058" ref-type="bibr">101</xref>,
     <xref rid="B102-viruses-12-01058" ref-type="bibr">102</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Favipiravir</bold>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broad-spectrum inhibitor of viral RNA, i.e., Influenza</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Raises serum uric acid</p>
      </list-item>
      <list-item>
       <p>Diarrhoea</p>
      </list-item>
     </list>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Inhibits viral RbRp in the genome replication process</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">currently ongoing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B23-viruses-12-01058" ref-type="bibr">23</xref>,
     <xref rid="B89-viruses-12-01058" ref-type="bibr">89</xref>,
     <xref rid="B103-viruses-12-01058" ref-type="bibr">103</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Ivermectin</bold>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Broad-spectrum anti-parasitic agent</td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported for COVID-19. Predicted as: 
     <list list-type="bullet">
      <list-item>
       <p>Nausea, rashes, dizziness</p>
      </list-item>
      <list-item>
       <p>Fever and tachycardia</p>
      </list-item>
     </list>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nuclear transport inhibitory activity of viral proteins</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In vitro studies</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B90-viruses-12-01058" ref-type="bibr">90</xref>,
     <xref rid="B104-viruses-12-01058" ref-type="bibr">104</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Remdesivir</bold>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Antiviral activity against RNA viruses, i.e., Ebola virus </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <list list-type="bullet">
      <list-item>
       <p>Abnormal liver function</p>
      </list-item>
      <list-item>
       <p>Renal impairment</p>
      </list-item>
      <list-item>
       <p>Hypotension, diarrhoea and rashes</p>
      </list-item>
     </list>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acts as RbRp inhibitor to target viral genome replication process</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Currently ongoing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B105-viruses-12-01058" ref-type="bibr">105</xref>,
     <xref rid="B106-viruses-12-01058" ref-type="bibr">106</xref>,
     <xref rid="B107-viruses-12-01058" ref-type="bibr">107</xref>]
    </td>
   </tr>
   <tr>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
     <bold>Baricitinib</bold>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">An orally bioavailable inhibitor of Janus kinases 1 and 2 (JAK1/2), with potential anti-inflammatory, immunomodulating and antineoplastic activities. Typically used to treat autoimmune disorders such as rheumatoid arthritis. </td>
    <td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Not reported for COVID-19. Previous original indication.
     <list list-type="bullet">
      <list-item>
       <p>Nausea</p>
      </list-item>
      <list-item>
       <p>Blurred vision</p>
      </list-item>
      <list-item>
       <p>Cold sores</p>
      </list-item>
      <list-item>
       <p>Shingles</p>
      </list-item>
      <list-item>
       <p>Possible increase in upper respiratory tract infection</p>
      </list-item>
      <list-item>
       <p>Hypercholesterolemia</p>
      </list-item>
      <list-item>
       <p>Hypertension</p>
      </list-item>
      <list-item>
       <p>Urinary tract infection</p>
      </list-item>
     </list>
    </td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">A high-affinity NAK inhibitor, especially on AP2-associated protein kinase 1 (AAK1), a pivotal regulator of clathrin-mediated endocytosis involved in viral entry at the lungs</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Currently ongoing</td>
    <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[
     <xref rid="B39-viruses-12-01058" ref-type="bibr">39</xref>,
     <xref rid="B108-viruses-12-01058" ref-type="bibr">108</xref>]
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
